Katalog GES

A framework for identification of actionable cancer genome dependencies in small cell lung cancer

Small cell lung cancer (SCLC) accounts for about 15% of all lung cancers. The prognosis of SCLC patients is devastating and no biologically targeted therapeutics are active in this tumor type. To develop a framework for development of specific SCLC-targeted drugs we conducted a combined genomic... Full description

1st Person: Sos, Martin L.
Additional Persons: Dietlein, Felix verfasserin; Peifer, Martin verfasserin; Schöttle, Jakob verfasserin; Balke-Want, Hyatt verfasserin; Müller, Christian verfasserin; Koker, Mirjam verfasserin; Richters, André verfasserin; Heynck, Stefanie verfasserin; Malchers, Florian verfasserin; Heuckmann, Johannes M. verfasserin; Seidel, Danila verfasserin; Eyers, Patrick A. verfasserin; Ullrich, Rolad T. verfasserin; Antonchick, Andrey P. verfasserin; Vintonyak, Viktor V. verfasserin; Schneider, Peter M. verfasserin; Ninomiya, Takashi verfasserin; Waldmann, Herbert verfasserin; Büttner, Reinhard verfasserin; Rauh, Daniel verfasserin; Heukamp, Lukas C. verfasserin; Thomas, Roman K. verfasserin
Source: in Proceedings of the National Academy of Sciences of the United States of America Vol. 109, No. 42 (2012), p. 17034-17039
More Articles
Type of Publication: Article
Language: English
Published: 2012
Keywords: research-article
Online: Volltext
  Search for full text



Similar Items

Cannot find similar records

Library Services

Search Options

Quick links